International journal of nanomedicine2026ReviewDrug Delivery
1. Long-Acting Nanomedicine for Tuberculosis: A Mechanism-Informed Framework
Herdiana Y
Tuberculosis treatment remains prolonged because effective therapy must maintain coordinated multidrug exposure across heterogeneous lesions, bacterial states, and intracellular compartments. Long-acting nanomedicine may reduce adherence-related vulnerability and improve drug delivery, but prolonged release alone do…
- PLGA
- Tuberculosis
- intracellular delivery
- lesion pharmacokinetics
- long-acting drug delivery
- multidrug therapy
- nanomedicine
